BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys (NASDAQ: CEGE), today announced that they have entered into a definitive merger ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE